{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:04:31Z","timestamp":1785499471927,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8217061288"],"award-info":[{"award-number":["8217061288"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.intimp.2023.110421","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:39:20Z","timestamp":1686404360000},"page":"110421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The enrichment of Arg1+ILC2s and ILCregs facilitates the progression of endometriosis: A preliminary study"],"prefix":"10.1016","volume":"121","author":[{"given":"Zhimin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaihuan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5389-1591","authenticated-orcid":false,"given":"Yunxia","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.intimp.2023.110421_b0005","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.intimp.2023.110421_b0010","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.cell.2021.04.041","article-title":"Endometriosis: Etiology, pathobiology, and therapeutic prospects","volume":"184","author":"Saunders","year":"2021","journal-title":"Cell."},{"issue":"6","key":"10.1016\/j.intimp.2023.110421_b0015","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/humrep\/det050","article-title":"World Endometriosis Society Montpellier Consortium, Consensus on current management of endometriosis","volume":"28","author":"Johnson","year":"2013","journal-title":"Hum. Reprod."},{"issue":"5","key":"10.1016\/j.intimp.2023.110421_b0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"24","key":"10.1016\/j.intimp.2023.110421_b0025","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1001\/jama.2018.17953","article-title":"Endometriosis","volume":"320","author":"Peiris","year":"2018","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.intimp.2023.110421_b0030","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1093\/humrep\/dew057","article-title":"Platelet-derived TGF-\u03b21 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis","volume":"31","author":"Guo","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.intimp.2023.110421_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jri.2018.02.003","article-title":"Treg and NK cells related cytokines are associated with deep rectosigmoid endometriosis and clinical symptoms related to the disease","volume":"126","author":"Gueuvoghlanian-Silva","year":"2018","journal-title":"J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110421_b0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.rbmo.2019.05.014","article-title":"CCR5\/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis","volume":"39","author":"Guo","year":"2019","journal-title":"Reprod. Biomed. Online."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0045","doi-asserted-by":"crossref","first-page":"e13067","DOI":"10.1111\/aji.13067","article-title":"CD33+ CD14+ CD11b+ HLA-DR- monocytic myeloid-derived suppressor cells recruited and activated by CCR9\/CCL25 are crucial for the pathogenic progression of endometriosis","volume":"81","author":"Sun","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12958-018-0325-2","article-title":"Suppressive regulatory T cells and latent transforming growth factor-\u03b2-expressing macrophages are altered in the peritoneal fluid of patients with endometriosis","volume":"16","author":"Hanada","year":"2018","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110421_b0055","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.molmed.2018.07.004","article-title":"The Immunopathophysiology of Endometriosis","volume":"24","author":"Symons","year":"2018","journal-title":"Trends. Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2023.110421_b0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.autrev.2018.03.017","article-title":"The link between immunity, autoimmunity and endometriosis: a literature update","volume":"17","author":"Zhang","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"7534","key":"10.1016\/j.intimp.2023.110421_b0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature."},{"issue":"5","key":"10.1016\/j.intimp.2023.110421_b0070","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate Lymphoid Cells: 10 Years On","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell."},{"issue":"7","key":"10.1016\/j.intimp.2023.110421_b0075","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/ni.3459","article-title":"The evolution of innate lymphoid cells","volume":"17","author":"Vivier","year":"2016","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2023.110421_b0080","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41577-021-00595-y","article-title":"The discovery of innate lymphoid cells","volume":"21","author":"Vivier","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"6237","key":"10.1016\/j.intimp.2023.110421_b0085","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science."},{"key":"10.1016\/j.intimp.2023.110421_b0090","doi-asserted-by":"crossref","first-page":"861","DOI":"10.3389\/fimmu.2019.00861","article-title":"Innate Lymphoid Cells in Mucosal Immunity","volume":"10","author":"Panda","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2023.110421_b0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nri.2017.86","article-title":"Innate lymphoid cells: major players in inflammatory diseases","volume":"17","author":"Ebbo","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110421_b0100","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ni.3484","article-title":"Innate lymphoid cell function in the context of adaptive immunity","volume":"17","author":"Bando","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110421_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109029","article-title":"Imbalance of circulating innate lymphoid cell subpopulations in patients with chronic kidney disease","volume":"239","author":"Wang","year":"2022","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110421_b0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2013a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.110421_b0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clim.2019.03.008","article-title":"Innate lymphoid cell disturbance with increase in ILC1 in systemic lupus erythematosus","volume":"202","author":"Guo","year":"2019","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110421_b0120","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","article-title":"Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells","volume":"38","author":"Fuchs","year":"2013","journal-title":"Immunity."},{"issue":"23","key":"10.1016\/j.intimp.2023.110421_b0125","doi-asserted-by":"crossref","first-page":"e149699","DOI":"10.1172\/jci.insight.149699","article-title":"IL-33 activates group 2 innate lymphoid cell expansion and modulates endometriosis","volume":"6","author":"Miller","year":"2021","journal-title":"JCI. Insight."},{"issue":"2","key":"10.1016\/j.intimp.2023.110421_b0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni.3078","article-title":"IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells","volume":"16","author":"Huang","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110421_b0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ebiom.2019.02.050","article-title":"NCR- group 3 innate lymphoid cells orchestrate IL-23\/IL-17 axis to promote hepatocellular carcinoma development","volume":"41","author":"Liu","year":"2019","journal-title":"EBioMedicine."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","article-title":"Regulatory Innate Lymphoid Cells Control Innate Intestinal Inflammation","volume":"171","author":"Wang","year":"2017","journal-title":"Cell."},{"issue":"9","key":"10.1016\/j.intimp.2023.110421_b0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","article-title":"Plasticity of innate lymphoid cell subsets","volume":"20","author":"Bal","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110421_b0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ni.2534","article-title":"Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues","volume":"14","author":"Bernink","year":"2013","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0155","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/cei.12996","article-title":"Enrichment of IL-17A+ IFN-\u03b3+ and IL-22+ IFN-\u03b3+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients","volume":"190","author":"Li","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110421_b0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ni.3443","article-title":"Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs","volume":"17","author":"Silver","year":"2016","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110421_b0165","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/ni.3444","article-title":"IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs","volume":"17","author":"Bal","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.110421_b0170","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.3389\/fimmu.2019.03111","article-title":"Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer","volume":"10","author":"An","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110421_b0175","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cdd.2014.134","article-title":"New insights into IL-12-mediated tumor suppression","volume":"22","author":"Tugues","year":"2015","journal-title":"Cell. Death. Differ."},{"key":"10.1016\/j.intimp.2023.110421_b0180","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1038\/ncomms9280","article-title":"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/ecco-jcc\/jjy119","article-title":"Distinct Alterations in the Composition of Mucosal Innate Lymphoid Cells in Newly Diagnosed and Established Crohn's Disease and Ulcerative Colitis","volume":"13","author":"Forkel","year":"2019","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.intimp.2023.110421_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/923135","article-title":"Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer","volume":"2014","author":"Bie","year":"2014","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110421_b0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","article-title":"Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria","volume":"43","author":"Bernink","year":"2015","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.110421_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789788","article-title":"Innate Lymphoid Cells in Autoimmune Diseases","volume":"12","author":"Clottu","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110421_b0205","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ni.3421","article-title":"Arginase 1 is an innate lymphoid cell-intrinsic metabolic checkpoint controlling type 2 inflammation","volume":"17","author":"Monticelli","year":"2016","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110421_b0210","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.jaci.2018.12.1018","article-title":"Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid","volume":"143","author":"Morita","year":"2019","journal-title":"J. Allergy. Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110421_b0215","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41422-020-0312-y","article-title":"Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer","volume":"30","author":"Wang","year":"2020","journal-title":"Cell. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923007440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:07:42Z","timestamp":1761588462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923007440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"alternative-id":["S1567576923007440"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110421","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enrichment of Arg1+ILC2s and ILCregs facilitates the progression of endometriosis: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110421"}}